Across TCGA pan-cancer cohorts, LINC02636 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC02636 data layer.
The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher LINC02636 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02636 expression acts as an unfavorable survival marker, although some lineages such as LGG and UCS show a favorable association.
DLBC, LGG, and UCS are the cancer types where LINC02636 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.